Magnetic resonance imaging in myelodysplastic syndromes.
In this study we used magnetic resonance imaging (MRI) to examine the axial bone marrow of 11 patients with myelodysplastic syndromes (MDS). T1 weighted images showed a reduction in signal intensity in all patients. The degree of reduction in signal intensity correlated with bone marrow cellularity rather than percentage blasts or French-American-British Co-operative group (FAB) classification. T2 weighted images showed an increase in signal intensity in 10 out of 11 patients; however, reliable grading was not possible using this sequence. Both T1 and T2 weighted images indicated a homogeneous pattern of disease within the axial skeleton in MDS. We have also shown that iron deposition in multiply transfused patients is a significant factor influencing signal reduction. The results of this study suggest that MRI may have a diagnostic role in MDS but is unlikely to be of value in staging.
Lewis
S
S
Haematology Department, John Radcliffe Hospital, Oxford, UK.
Wainscoat
J S
JS
Moore
N R
NR
Golding
S J
SJ
D000328:Adult; D000368:Aged; D000753:Anemia, Refractory / Q000473:pathology*; D000754:Anemia, Refractory, with Excess of Blasts / Q000473:pathology; D001803:Blood Transfusion; D001853:Bone Marrow / Q000473:pathology*; D005260:Female; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged